Galderma Group AG (GALD.SW) News
Track canonical SquawkNews coverage tagged to GALD.SW, Galderma Group AG. This hub brings together deduplicated headlines about swiss, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
RBC Expects Slowdown in Galderma's Q2 Sales Growth; Price Target, Estimates Revised
() -- RBC Capital Markets anticipates a deceleration in Galderma Group's (GALD.SW) second-quarter constant-currency sales growth, as the research firm adjusted its price target and earnings forecasts for the Swiss dermat
EARNINGS | Jul 09, 2026, 06:58 AM UTC
H
Swiss Market Index Slips Back into Red; Barry Callebaut Shares Down
() -- Swiss equities fell back into negative territory on Wednesday, reflecting cautious investor sentiment as geopolitical tensions between the US and Iran re-escalated. Joining a regional retreat in Europe, the Swiss M
RATES | Jul 08, 2026, 03:52 PM UTC
H
Galderma Group Forecasts Revised as BofA Notes US FDA Response to Relfydess Application
() -- BofA Global Research adjusted its forecasts for Galderma Group (GALD.SW) as it took note of the second complete response letter from the US Food and Drug Administration for the group's Relfydess neuromodulator. "Ma
RATES | Jul 03, 2026, 11:02 AM UTC